2012 - 2013: Gefälschte Malariamittel in Papua-Neuguinea (2)
The Institute of Medical Research in Papua New Guinea (PNG) together with the Swiss Tropical and Public Health Institute monitored the quality of a selected range of vital antimalarial medicines in PNG’s health facility supply chain. As an extension of the work done by the Global Pharma Health Fund and Frankfurt University, the follow-up study proofed again the existence of poor-quality antimalarial medicines collected throughout the country in 2012 and 2013. For example, the content of the malaria medicines amodiquine from some "Infant Camaquine" batches were in general 50% below the label claim. Whether done on purpose or unintentionally by poor manufacturing requires further investigation. For further readings go to the Facebook Wall "Minilabs Save Lives".